Skip to content
10-Q

Quarterly Report

MERA PHARMACEUTICALS INC

0001354488-12-003655

← back to feed
Filed
Jul 26, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Jul 26, 2012 557.3M sh
Capex Q3 2011 · Jul 31, 2011 $2.29K
Capex Q3 2011 · Jul 31, 2010 $150K
Operating Cash Flow Q3 2011 · Jul 31, 2011 $356
Operating Cash Flow Q3 2011 · Jul 31, 2010 $147.72K
Cash And Equivalents Q3 2011 · Jul 31, 2011 $4.01K
Cash And Equivalents Q3 2011 · Oct 31, 2010 $5.94K
Stockholders Equity Q3 2011 · Jul 31, 2011 −$762.44K
Stockholders Equity Q3 2011 · Oct 31, 2010 −$676.94K
Current Liabilities Q3 2011 · Jul 31, 2011 $847.22K
Current Liabilities Q3 2011 · Oct 31, 2010 $750.3K
Current Assets Q3 2011 · Jul 31, 2011 $50.59K
Current Assets Q3 2011 · Oct 31, 2010 $14.8K
Total Assets Q3 2011 · Jul 31, 2011 $84.78K
Total Assets Q3 2011 · Oct 31, 2010 $73.36K
Sga Expense Q3 2011 · Jul 31, 2011 $63.91K
Sga Expense Q3 2011 · Jul 31, 2011 $188.22K
Sga Expense Q3 2011 · Jul 31, 2010 $38.28K
Sga Expense Q3 2011 · Jul 31, 2010 $145.52K
Rd Expense Q3 2011 · Jul 31, 2011 $40.56K
Rd Expense Q3 2011 · Jul 31, 2011 $127.79K
Rd Expense Q3 2011 · Jul 31, 2010 $70.26K
Rd Expense Q3 2011 · Jul 31, 2010 $203.67K
Net Income Q3 2011 · Jul 31, 2011 −$15.75K
Net Income Q3 2011 · Jul 31, 2011 −$85.5K
Net Income Q3 2011 · Jul 31, 2010 −$48.12K
Net Income Q3 2011 · Jul 31, 2010 −$143.29K
Operating Income Q3 2011 · Jul 31, 2011 −$20.06K
Operating Income Q3 2011 · Jul 31, 2011 −$97.5K
Operating Income Q3 2011 · Jul 31, 2010 −$52.58K
Operating Income Q3 2011 · Jul 31, 2010 −$157.14K
Gross Profit Q3 2011 · Jul 31, 2011 $86.54K
Gross Profit Q3 2011 · Jul 31, 2011 $224.68K
Gross Profit Q3 2011 · Jul 31, 2010 $67.12K
Gross Profit Q3 2011 · Jul 31, 2010 $214.34K
Cost Of Revenue Q3 2011 · Jul 31, 2011 $284
Cost Of Revenue Q3 2011 · Jul 31, 2011 $14.03K
Cost Of Revenue Q3 2011 · Jul 31, 2010 $0
Cost Of Revenue Q3 2011 · Jul 31, 2010 $10.4K